Inicio › Cáncer de ovario › Maine
Ensayos clínicos de Cáncer de ovario en Maine
9 estudios sobre Cáncer de ovario buscan participantes en Maine.
Ciudades en Maine
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Harold Alfond Center for Cancer Care, Augusta
- Lafayette Family Cancer Center-EMMC, Brewer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
- y 1 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 2 oct 2026 · NCT05564377A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Maine Medical Center - Scarborough Campus /ID# 277205, Scarborough
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 22 sept 2026 · NCT07059845A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Maine Medical Center - Scarborough Campus, Scarborough
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0060), Scarborough
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 17 sept 2026 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Maine Center For Cancer Medicine, Scarborough
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 sept 2026 · NCT07214779A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0008), Scarborough
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT06824467A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- MaineHealth Maine Medical Center - Portland, Portland
- MaineHealth Maine Medical Center- Scarborough, Scarborough
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06580314SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scarborough
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.